Initial Results of the Study of Tamoxifen and Raloxifene or STAR, released today revealed the osteoporosis drug raloxifene has been proved to be as effective as tamoxifen in preventing invasive breast cancer.
Vanderbilt University Medical Center’s LifeFlight air ambulance program has become the first program in Tennessee to receive accreditation from the Commission on Accreditation of Medical Transport Systems (CAMTS).
Tony Bland, a 15-year veteran of Vanderbilt’s LifeFlight, has been named “EMT of the Year” by the Tennessee Ambulance Service Association.
Researchers at the Vanderbilt-Ingram Cancer Center are studying whether exercise can help curb memory and cognitive problems experienced by many cancer survivors following chemotherapy.
A disturbing nationwide trend has been documented by a researcher at the Monroe Carell Jr. Children’s Hospital at Vanderbilt.
Ginseng, one of the most widely used herbs in traditional Chinese medicine, may improve survival and quality of life after a diagnosis of breast cancer, according to a recent study by Vanderbilt-Ingram Cancer Center researchers. The large epidemiological study, led by Xiao-Ou Shu, M.D., Ph.D., was published online recently in the American Journal of Epidemiology.